
Novo Nordisk and Orsted troubles spark fears Denmark faces its own 'Nokia moment'
AT THEIR heights, Denmark’s corporate champions seemed untouchable.Novo Nordisk, long known mostly as an insulin maker, was Europe’s most valuable company last year — after riding a surge of demand for Ozempic and Wegovy. That followed the success of …